HCA Healthcare, Inc. (NYSE:HCA) Shares Acquired by Ballentine Partners LLC

Ballentine Partners LLC lifted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 2.7% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,113 shares of the company’s stock after buying an additional 107 shares during the quarter. Ballentine Partners LLC’s holdings in HCA Healthcare were worth $1,672,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of HCA. NorthRock Partners LLC lifted its holdings in shares of HCA Healthcare by 17.4% in the 1st quarter. NorthRock Partners LLC now owns 1,310 shares of the company’s stock valued at $437,000 after purchasing an additional 194 shares during the last quarter. Hennessy Advisors Inc. purchased a new position in shares of HCA Healthcare during the first quarter worth approximately $3,269,000. Norway Savings Bank boosted its stake in HCA Healthcare by 51.9% during the 1st quarter. Norway Savings Bank now owns 1,183 shares of the company’s stock worth $395,000 after purchasing an additional 404 shares during the period. New Mexico Educational Retirement Board increased its stake in HCA Healthcare by 29.9% in the first quarter. New Mexico Educational Retirement Board now owns 13,900 shares of the company’s stock valued at $4,636,000 after purchasing an additional 3,200 shares during the period. Finally, Red Door Wealth Management LLC grew its holdings in shares of HCA Healthcare by 4.6% during the first quarter. Red Door Wealth Management LLC now owns 19,868 shares of the company’s stock worth $6,627,000 after buying an additional 881 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

HCA has been the topic of several analyst reports. StockNews.com upgraded HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Monday, July 1st. Oppenheimer boosted their price objective on shares of HCA Healthcare from $345.00 to $390.00 and gave the company an “outperform” rating in a research note on Wednesday, July 24th. Wolfe Research upgraded shares of HCA Healthcare to a “strong-buy” rating in a research note on Thursday, August 29th. UBS Group lifted their price objective on HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a report on Wednesday, August 14th. Finally, Wells Fargo & Company lifted their price target on HCA Healthcare from $365.00 to $395.00 and gave the company an “equal weight” rating in a research note on Tuesday. Five investment analysts have rated the stock with a hold rating, twelve have issued a buy rating and four have given a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $377.17.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the transaction, the executive vice president now owns 29,678 shares of the company’s stock, valued at $11,438,494.76. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the sale, the executive vice president now owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Kathleen M. Whalen sold 2,987 shares of HCA Healthcare stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total value of $1,085,804.37. Following the completion of the transaction, the senior vice president now directly owns 9,454 shares in the company, valued at $3,436,623.54. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 15,345 shares of company stock worth $5,747,945 in the last three months. Company insiders own 1.60% of the company’s stock.

HCA Healthcare Trading Down 8.8 %

HCA Healthcare stock opened at $363.75 on Friday. HCA Healthcare, Inc. has a 52 week low of $220.55 and a 52 week high of $417.14. The stock has a market cap of $95.27 billion, a PE ratio of 18.13, a P/E/G ratio of 1.44 and a beta of 1.67. The stock has a 50-day moving average price of $395.26 and a 200 day moving average price of $352.63. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11.

HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, topping the consensus estimate of $4.97 by $0.53. The firm had revenue of $17.49 billion during the quarter, compared to analysts’ expectations of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. HCA Healthcare’s revenue for the quarter was up 10.3% on a year-over-year basis. During the same period in the previous year, the company earned $4.29 EPS. Equities research analysts predict that HCA Healthcare, Inc. will post 22.51 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be issued a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.73%. HCA Healthcare’s dividend payout ratio (DPR) is 13.16%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.